Chile‘s health regulator on Monday approved the use of Chinese laboratory Sinovac‘s COVID-19 vaccine for children over the age of six, allowing them to be included in the country’s mass, rapid immunization program.

The South American country has used Sinovac’s formula as the flagship of its successful program, which has already been completed by more than 13 million of its 19 million people.

Until now, the Pfizer-BioNTech vaccine was the only one used in children aged 12 and older, and Colombia recently gave nod to the vaccination of people over 12 years old with this vaccine.

(Translated and co-written by LABS)